Clinical Trials

Inclusion Criteria:

• Women ≥ 18 years of age and ≤ 80 years of age.
• Have diagnosis of symptomatic uterovaginal prolapse.
• Have elected to undergo surgical management of uterovaginal prolapse after consultation with their physician.
• Are eligible for both minimally invasive supracervical hysterectomy with sacrocolpopexy (MI-SCH+SCP) and total vaginal hysterectomy with uterosacral ligament suspension (TVH+USLS).

Exclusion Criteria:

• Patients who wish to undergo uterine sparing procedures.
• Body mass index BMI) > 50.
• Previous hysterectomy or prior uterovaginal surgery.
• Have a diagnosis of neurogenic bladder, Parkinson's disease, multiple sclerosis, spinal cord injury, or cerebrovascular accident.
• Chronic indwelling urinary catheter.
• Urinary diversion of any type.
• Any condition or disorder that, in the opinion of the investigator, might prevent the subject from completing the study or interfere with the interpretation of the study results.
• Unable to speak, read, understand English.

Eligibility last updated 6/6/22. Questions regarding updates should be directed to the study team contact.